(Q21245661)

English

Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients

scientific article

In more languages

Statements

scholarly article

0 references

Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients (English)

0 references

author name string

Pedro C Rodriguez

1

author given names

Pedro C

author last names

Rodriguez

1 reference

Dimensions Publication ID

19 August 2022

Elia Neninger

2

author given names

Elia

author last names

Neninger

1 reference

Dimensions Publication ID

19 August 2022

Beatriz García

3

author given names

Beatriz

author last names

García

1 reference

Dimensions Publication ID

19 August 2022

Xitlally Popa

4

author given names

Xitlally

author last names

Popa

1 reference

Dimensions Publication ID

19 August 2022

Carmen Viada

5

author given names

Carmen

author last names

Viada

1 reference

Dimensions Publication ID

19 August 2022

Patricia Luaces

6

author given names

Patricia

author last names

Luaces

1 reference

Dimensions Publication ID

19 August 2022

Gisela González

7

author given names

Gisela

author last names

González

1 reference

Dimensions Publication ID

19 August 2022

Agustin Lage

8

author given names

Agustin

author last names

Lage

1 reference

Dimensions Publication ID

19 August 2022

Enrique Montero

9

author given names

Enrique

author last names

Montero

1 reference

Dimensions Publication ID

19 August 2022

Tania Crombet

10

author given names

Tania

author last names

Crombet

1 reference

Dimensions Publication ID

19 August 2022

language of work or name

0 references

publication date

2011

0 references

Journal of immune based therapies and vaccines

1 reference

9

0 references

1

0 references

7

0 references

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

EGFR pathway in advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Management of unfit older patients with advanced NSCLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Autoimmunization to epidermal growth factor, a component of the immunological homunculus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Regulation of the immune response by antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

12 September 2017

Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

27 September 2017

SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

30 May 2018

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth f

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.

1 reference

https://api.crossref.org/works/10.1186%2F1476-8518-9-7

21 January 2018

Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215653

29 November 2018

Enhanced immune priming with spatial distribution of paracrine cytokine vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22024351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial distribution of tumor vaccine improves efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22024351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1476-8518-9-7

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21245661&oldid=2176706618"